Abstract
This presentation will focus on the treatment of autoimmune encephalopathies (AEs), including immunomodulatory treatments and supportive therapies. AE is a broad category of autoimmune brain disease, representing numerous diagnoses, with a range of symptoms and severity. As a result, there are different treatment recommendations based on the clinical features and specific diagnosis. It is important for all providers to recognize the heterogeneity in treatment responses across the spectrum of AE and across immunomodulatory therapies. Understanding the expected timeline for improvement after different therapies is essential to accurately assessing effectiveness of treatment and determining which supportive therapies may be necessary.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
